Years of meticulous research led to a pivotal discovery when a scientist modified RNA to mimic transfer RNA, resulting in a significant reduction in immune response and a tenfold increase in protein production. Despite the groundbreaking findings published in 2005, the initial lack of interest from the pharmaceutical industry highlights the challenges faced in advancing RNA technology, even when the potential was clear.
